Related Experiment Video
Updated: Jan 10, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Emerging moulds: epidemiological trends and antifungal resistance
Marisa H Miceli1, Samuel A Lee
1Department of Internal Medicine, Oakwood Hospital and Medical Center, Dearborn, MI, USA.
Abstract:
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in immunocompromised patients. Although Aspergillus spp. remain an important cause of IFI, other moulds such as Fusarium spp., dematiaceous fungi and Mucorales have become increasingly prevalent among this patient population. Diagnosis and treatment of invasive mould infections remain a challenge. Because of the poor prognosis associated with IFIs, understanding the activity, efficacy and limitations of the available drugs is critical to select the appropriate antifungal agent on an individualised basis.
Insights
Invasive fungal infections (IFIs) pose significant risks to immunocompromised individuals. Understanding antifungal drug activity is crucial for effective treatment of these challenging infections.
Area of Science:
- Mycology
- Infectious Diseases
- Pharmacology
Background:
- Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in immunocompromised patients.
- While Aspergillus species are common, other fungi like Fusarium, dematiaceous fungi, and Mucorales are increasingly prevalent.
- Diagnosis and treatment of invasive mould infections present significant clinical challenges.
Purpose of the Study:
- To highlight the challenges in diagnosing and treating invasive mould infections.
- To emphasize the critical need for understanding antifungal drug profiles.
- To guide the selection of appropriate antifungal agents for individual patients.
Main Methods:
- Review of current literature on invasive fungal infections.
- Analysis of the spectrum of activity, efficacy, and limitations of available antifungal drugs.
- Discussion of diagnostic and therapeutic strategies.
Main Results:
- Invasive mould infections are increasingly caused by a diverse range of fungi beyond Aspergillus.
- Effective management requires a thorough understanding of drug pharmacodynamics and pharmacokinetics.
- Individualized treatment approaches are essential due to varying patient conditions and fungal pathogens.
Conclusions:
- The rising prevalence of diverse fungal pathogens necessitates updated treatment guidelines.
- Optimizing antifungal therapy requires careful consideration of drug efficacy and patient-specific factors.
- Further research into novel antifungal agents and treatment strategies is warranted.
Related Concept Videos
Overview of Fungi
Fungal Phylum Ascomycota
Antimicrobial Effectiveness
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Development of Antibiotic Resistance

